Hunan Jingfeng Pharmaceutical News

*ST Jingfeng: Announcement on the company\'s major litigation

Nov 4 11:00 ET

*ST Jingfeng: Legal Opinion of Guangdong Chongli Law Firm on the 2024 Fourth Extraordinary General Meeting of Shareholders of Hunan Jingfeng Pharmaceutical Co., Ltd.

Nov 4 11:00 ET

*ST Jingfeng: Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders

Nov 4 11:00 ET

*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading

Nov 3 11:00 ET

*ST Jingfeng: Notice on receipt of the court\'s decision to postpone pre-restructuring

Nov 1 12:00 ET

*ST Jingfeng: Report for the third quarter of 2024

Oct 30 12:00 ET

*ST Jingfeng: Progress announcement on pre-restructuring matters

Oct 30 12:00 ET

*ST Jingfeng: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the fiduciary management affairs of Hunan Jingfeng Pharmaceutical Co., Ltd.\'s public offering of corporate bonds to qualified investors in 2016 (Phase 1)

Oct 25 06:06 ET

*ST Jingfeng: Articles of Association (revised in October 2024)

Oct 24 12:00 ET

*ST Jingfeng: Legal Opinion of Guangdong Chongli Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Hunan Jingfeng Pharmaceutical Co., Ltd.

Oct 24 12:00 ET

*ST Jingfeng: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders

Oct 24 12:00 ET

*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading

Oct 23 12:00 ET

*ST Jingfeng: Announcement on subsidiaries providing guarantees to subsidiaries and accepting guarantees from related parties

Oct 18 12:00 ET

*ST Jingfeng: Announcement on Launching Financial Leasing and Related Transactions

Oct 18 12:00 ET

*ST Jingfeng: Announcement of Resolutions of the 33rd Meeting of the Eighth Board of Directors

Oct 18 12:00 ET

*ST Jingfeng: Announcement on the launch of commissioned research and development and daily related transactions

Oct 18 12:00 ET

*ST Jingfeng: Notice on Convening the Fourth Extraordinary General Meeting of Shareholders in 2024

Oct 18 12:00 ET

*ST Jingfeng: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the fiduciary management affairs of Hunan Jingfeng Pharmaceutical Co., Ltd.\'s public offering of corporate bonds to qualified investors in 2016 (Phase 1)

Oct 16 05:18 ET

*ST Jingfeng: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the fiduciary management affairs of Hunan Jingfeng Pharmaceutical Co., Ltd.\'s public offering of corporate bonds to qualified investors in 2016 (Phase 1)

Oct 14 05:06 ET

*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading

Oct 13 12:00 ET